Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)
RecruitingNCT07258914Phase: NAStarted 2024-12-19
Summary
Depression is a common complication of Autism Spectrum Disorder (ASD): it is four times more prevalent in people with ASD than in the general population. However, treating depression in people with A
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Centre Hospitalier Guillaume RégnierRennes, France
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07258914